Health Care & Life Sciences » Pharmaceuticals | Towa Pharmaceutical Co. Ltd.

Towa Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
61,351
71,470
82,115
84,949
93,430
105,104
Cost of Goods Sold (COGS) incl. D&A
31,121
34,487
40,261
45,902
50,379
56,705
Gross Income
30,230
36,983
41,854
39,047
43,051
48,399
SG&A Expense
14,522
17,422
21,185
31,904
31,407
32,116
EBIT
15,708
19,561
20,669
7,143
11,644
16,283
Unusual Expense
377
3,085
2,296
505
3,134
1,057
Non Operating Income/Expense
612
1,031
1,125
736
1,423
1,644
Interest Expense
122
135
163
164
158
146
Pretax Income
8,702
15,206
9,903
7,237
9,833
18,886
Income Tax
2,710
4,088
2,219
1,661
3,338
5,410
Consolidated Net Income
5,992
11,118
7,684
5,576
6,495
13,475
Net Income
5,992
11,118
7,684
5,576
6,495
13,475
Net Income After Extraordinaries
5,992
11,118
7,684
5,576
6,495
13,475
Net Income Available to Common
5,992
11,118
7,684
5,576
6,495
13,475
EPS (Basic)
352.61
654.18
462.54
339.94
395.96
273.83
Basic Shares Outstanding
17
17
17
16
16
49
EPS (Diluted)
352.57
654.18
436.31
314.23
366.09
253.31
Diluted Shares Outstanding
17
17
18
18
18
53
EBITDA
21,115
25,285
27,998
15,123
19,817
24,623
Non-Operating Interest Income
46
110
103
29
58
48

About Towa Pharmaceutical Co.

View Profile
Address
2-11 Shinbashi-cho
Kadoma Osaka 571
Japan
Employees -
Website http://www.towayakuhin.co.jp
Updated 07/08/2019
Towa Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its products include neurological and anti-allergic drugs, cardiovascular and respiratory drugs, gastrointestinal drugs, antibiotics and chemotherapeutic drugs, vitamins; hormone drugs, and other metabolic drugs. The company was founded in June 1951 and is headquartered in Osaka, Japan.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.